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1. Introduction 
Tyrosine aminotransferase (EC 2.6.1.5) undergoes 
unusually rapid turnover in vivo in both rat liver [1-3] 
and hepatoma (HTC) cell cultures [4]. The mechanism 
responsible for tyrosine aminotransferase (TAT) degra- 
dation has not yet been identified probably because of 
the difficulty of reproducing TAT degradation i
homogenates. In fact homogenization f rat liver [5] 
and of hepatoma (HTC) cells (F. Auricchio, unpublished 
observations) tops TAT degradation. In order to cha- 
racterize and purify the system(s) responsible for TAT 
degradation i vivo, conditions have been sought under 
which TAT can also be degraded in vitro. 
In the present study we have demonstrated that 
TAT inactivation proceeds in rat liver homogenates 
when an acid buffer is used. This inactivation isdue 
to a thermolabile protein system which is probably 
composed of two components. The system seems to 
be localized in lysosomes and is strongly activated by 
-SH donors. A preliminary "rough" purification of 
this system is also reported. Triamcinolone, a gluco- 
corticosteroid that induces TAT formation in rat 
liver [6] does not change the level of this system. 
2. Materials and methods 
Male Wistar rats were used. Induction of rat liver 
TAT by triamcinolone (9a-fluoro- 16~-hydroxypred- 
nisolone diacetate) was obtained as previously des- 
cribed [7]. Rat livers were homogenized in an all- 
glass Dounce homogenizer. The buffer used in most 
experiments was a citrate buffer, pH 5, obtained by 
mixing 51.5 volumes of 0.2 M Na2 HPO4 and 48.5 
volumes of 0.1 M citric acid. "Stable" TAT was pre- 
pared following preliminary purification steps (in- 
cluding heat treatment) according to a previously 
published procedure [7]. 
The fractionation of rat liver homogenate by dif- 
ferential centrifugation was performed in the follo- 
wing way: the livers were gently homogenized in 
0.25 M sucrose with a Potter-Elvehjem homogenizer. 
The homogenate was filtered through several layers 
of cheese cloth and centrifuged at 755 g for 10 min. 
The resultant pellet was labeled "nuclear fraction". 
The supernatant was centrifuged at 12.100 g for 10 
min; this latter pellet represents he mitochondrial- 
lysosomal fraction. The supernatant was centrifuged 
at 105,000g for 90 min. The pellet was labeled "mi- 
crosomal fraction". 
TAT activity was assayed and its units calculated 
as previously reported [7]. The protein content was 
measured with the biuret reagent. Acid c~-glucosidase 
a.t ,ity was measured as reported in a previous paper 
[8]. 
3. Results and discussion 
Fig. 1 shows that incubation of liver homogenates 
of triamcinolone-treated rats, at 37 ° in citrate buffer, 
pH 5, induces an inactivation of TAT. The half-time 
of inactivation is about 4.5 hr. This value is within 
the range of the values obtained for TAT degradation 
in vivo [1-4].  
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Fig. 1.4 rats were killed 10 hr after triamcinolone treatment. 
The livers were homogenized in 5 volumes of citrate buffer, 
pH 5, and incubated at 37 °. At the indicated intervals TAT 
activity was assayed in the incubation mixture. TAT specific 
activity at 0 time was 0.3 units/mg protein. 
No TAT inactivation was observed under identical 
experimental conditions, when the buffer used was 
changed to 0.05 M potassium phosphate buffer pH 7.6, 
with 10 -3 M EDTA and 10 -a M dithiothreitol. 
Homogenization of rat livers in citrate buffers of 
different pHs, followed by incubation at 37 ° for 8.hr, 
results in TAT inactivation curves of the type presented 
in fig. 1. However, different slopes are obtained for 
different pHs. The rate of inactivation of TAT was 
calculated from these curves in arbitrary units and 
plotted against he pH values of the buffers used in 
the incubation (fig. 2). This plot shows that, in our 
experimental conditions, TAT inactivation is not due 
to acid denaturation, because if this were the case, one 
would expect he efficiency of TAT inactivation to 
progressively increase with the decrease of the pH. 
Furthermore, TAT inactivation may be due to the 
action of two components with different pH optima 
(fig. 2). It should be pointed out that it seems likely 
that several enzymes are involved in the lysosomal 
degradation of globin [9]. When liver homogenate 
of triamcinolOne-treated rats was incubated in citrate 
buffer, pH 4.5, at two different emperatures (37 ° 
and 4°), inactivation of TAT after 8 hr was of about 
40 and zero percent of the initial activity respectively 
(table 1). 
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Fig. 2. pH-dependence of TAT inactivation rate in liver 
homogenate of triamcinolone-treated rats. Experimental 
conditions, except for pH values, were identical to those of 
the experiment presented in fig. l. For further details ee 
text. 
TAT inactivation rate in liver homogenate of tri- 
amcinolone-treated rats is identical to that of the 
homogenate of livers of the control animals. Further- 
more the TAT degradation rate in vivo is similar for 
both the livers of rats treated and not treated with 
glucocorticosteroids [ I -3 ] .  This fact, also, suggests 
that in our experimental conditions TAT inactivation 
is due to the same system which is involved in TAT 
degradation i rive. 
We have performed a preliminary purification of 
TAT from rat liver according to a previously pub- 
lished procedure, which up to now is the only one 
giving pure rat liver TAT [7]. The partially purified 
TAT was incubated in citrate buffer, pH 5, at 37°for 
8 hr. During this time the TAT preparation is stable 
(table 1). This fact confirms that TAT inactivation 
in the experiments previously presented is not due 
to a pH-dependent denaturation of the enzyme. 
When "stable" TAT (e.g. partially purified TAT, 
free, from the inactivating system) is incubated in 
citrate buffer in the presence of equal amounts of 
ratiliver homogenate from rats treated or not with 
triamcinolone its activity is lost. The TAT inactiva- 
tion rate is very similar in both cases. Therefore, we 
conclude that treatment with triamcinolone, an in- 
ducer of TAT [6], does not change the levels of  the 
TAT inactivating system. 
Heating of rat liver homogenate at 67 ° for 7 rain 
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Table 1 
Inactivation of rat liver TAT incubated under 
different conditions in citrate buffer. 
Time of % Condition incubation (hr) Inactivation 
Homogenate a, pH 4.5 
37 ° 8 40 
4 ° 8 0 
"Stable" TAT b, pH 5, 
37 ° 8 0 
"Stable" TAT c, pH 5, 37 ° 
+ homogenate 4 67 
+ heated homogenate 4 0 
"Stable" TAT d + purified 
inactivating system, pH 5, 
37 ° 2 37 
+ 10 mM cysteine 2 90 
+ 10 mM dithiotreitol 2 92 
a Protein concentration: 20mg/ml, TAT specific activity: 
0.2 units/mg protein. 
b Protein content: 10 mg/ml, TAT specific activity: 8 units] 
mg protein. 
c "Stable" TAT: 2 units/ml, homogenate protein: 20 mg/ml. 
TAT specific activity of the homogenate: 0.012 units/rag 
protein. 
d "Stable" TAT: 1 unit]ml, inactivating system protein: 
1 mg/ml. 
completely destroys the capacity of the liver to inac- 
tivate pure TAT (table 1). 
When rat liver homogenate was fractionated by 
differential centrifugation and equal amounts of 
protein from the different fractions were incubated 
in citrate buffer with identical amounts of "stable" 
TAT, the fraction containing mitochondria nd 
lysosomes was by far the most active in inactivating 
"stable" TAT (fig. 3). The purification factor of the 
TAT inactivating system in the mitochondrial- lysosomal 
fraction over the crude homogenate was identical 
(7 fold) to that of the acid ct-glucosidase, anenzyme 
which is present in the lysosomes [10]. This fact 
together with the acid pH optimum of the TAT 
inactivating system strongly suggests that this system 
is localized in the lysosomes even if the present expe- 
riments do not exclude the possibility of a mito- 
chondrial localization. When the subcellular fraction 
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Fig. 3. "Stable ''• TAT inactivation by liver subcellular f ac- 
tions. Homogenate was fractionated by differential centri- 
fugation (see text). Fractions were frozen, thawed and dia- 
lized overnight against citrate buffer, pH 5, at 4 ° and subse- 
quently diluted with the same buffer to the same protein 
concentration. The single fractions were separately incubated 
with "stable" TAT in citrate buffer, pH 5, at 37 °. One ml of 
mixture contained 8 mg of subcellular fraction protein and 
2.2 units of "stable" TAT. At the indicated intervals TAT 
activity was measured in the incubation mixtures. 
Symbols: ohomogenate, • nuclear fraction, x mitochondrial- 
lysosomal fraction, zx microsomal fraction, [] 105,000 g super- 
natant. 
containing the TAT-inactivating system is frozen, 
thawed, dialyzed overnight against citrate buffer 
(pH 5, at 4°), and centrifuged at 10,000 rpm for 30 
min, the system is found in the supernatant and it is 
purified about 30 fold over the homogenate. 
When the purified inactivating system was incuba- 
ted with "stable" TAT in citrate buffer pH 5, in the 
presence of 10 mM cysteine or 10 mM dithiothreitol, 
TAT inactivation was strongly increased (table 1). 
In conclusion, from our experimental data we 
report the existence of a TAT inactivating system in 
the rat liver homogenate which is likely to be respon- 
sible, at least in part, for TAT degradation i vivo. 
The preliminary characterization a d purification 
here reported will probably help in the elucidation 
of the complex mechanism responsible for protein 
degradation i mammalian ceils. 
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